Suppr超能文献

肢端肥大症中的糖尿病视网膜病变

Diabetic retinopathy in acromegaly.

作者信息

Azzoug Said, Chentli Farida

机构信息

Department of Endocrine and Metabolic Diseases, Bab El Oued Hospital, 5boulevard Said Touati, Algiers, 16000, Algeria.

出版信息

Indian J Endocrinol Metab. 2014 May;18(3):407-9. doi: 10.4103/2230-8210.131207.

Abstract

INTRODUCTION

Although growth hormone (GH) has been implicated in the pathogenesis of diabetic retinopathy (DR), DR is deemed to be rare in patients with GH excess. Our aim was to study its prevalence in subjects with acromegaly suffering from diabetes mellitus (DM), to analyze its characteristics, and to look for predictive factors such as age at diagnosis, GH concentration and duration, DM duration, DM control, and family background.

MATERIALS AND METHODS

Forty patients with acromegaly and DM (21 males, 19 females), median age = 50 years, underwent a systematic ophthalmological examination with dilated funduscopy to seek diabetic retinopathy.

RESULTS

Among this population, 05 (12.5%) had DR. It was at an early stage or background retinopathy in 3 cases and at a more advanced stage or proliferative retinopathy in 2 cases. We did not find any correlation with age at diagnosis, GH levels and duration, DM duration and family history of DM, but poor glycemic control seems to play a role although statistical analysis showed borderline significance.

CONCLUSION

From this study, we conclude that prevalence of DR in patients with acromegaly is 12.5%, and it is slight or moderate. Among studied factors, only poor glycemic control seems to be implicated in its development.

摘要

引言

尽管生长激素(GH)被认为与糖尿病视网膜病变(DR)的发病机制有关,但在生长激素分泌过多的患者中,DR被认为是罕见的。我们的目的是研究肢端肥大症合并糖尿病(DM)患者中DR的患病率,分析其特征,并寻找预测因素,如诊断时的年龄、GH浓度和病程、DM病程、DM控制情况以及家族背景。

材料与方法

40例肢端肥大症合并DM患者(男21例,女19例),中位年龄50岁,接受了散瞳眼底镜的系统眼科检查以筛查糖尿病视网膜病变。

结果

在这组人群中,5例(12.5%)患有DR。其中3例处于早期或背景性视网膜病变阶段,2例处于更晚期或增殖性视网膜病变阶段。我们未发现其与诊断时的年龄、GH水平和病程、DM病程以及DM家族史之间存在任何相关性,但血糖控制不佳似乎起了作用,尽管统计分析显示其具有临界显著性。

结论

通过本研究,我们得出结论,肢端肥大症患者中DR的患病率为12.5%,程度较轻或中等。在所研究的因素中,只有血糖控制不佳似乎与DR的发生有关。

相似文献

1
Diabetic retinopathy in acromegaly.
Indian J Endocrinol Metab. 2014 May;18(3):407-9. doi: 10.4103/2230-8210.131207.
2
Diabetic retinopathy in acromegaly.
Ophthalmologica. 1978;176(2):74-80. doi: 10.1159/000308696.
3
Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario.
Indian J Ophthalmol. 2018 Apr;66(4):541-546. doi: 10.4103/ijo.IJO_1062_17.
4
Prevalence of Diabetic Retinopathy in a Clinic Population from Puerto Rico.
Optom Vis Sci. 2016 Jul;93(7):750-3. doi: 10.1097/OPX.0000000000000854.
9
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13.
10
Peripapillary Retinal Nerve Fiber Layer Changes in Patients with Diabetes Mellitus: A Case-control Study.
Semin Ophthalmol. 2020 May 18;35(4):257-260. doi: 10.1080/08820538.2020.1810289. Epub 2020 Aug 22.

引用本文的文献

1
Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat.
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):17. doi: 10.1167/iovs.65.13.17.
2
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management.
Nat Rev Endocrinol. 2024 Sep;20(9):541-552. doi: 10.1038/s41574-024-00993-x. Epub 2024 Jun 6.
3
Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited.
Front Endocrinol (Lausanne). 2022 Sep 9;13:994898. doi: 10.3389/fendo.2022.994898. eCollection 2022.
4
Advanced proliferative diabetic retinopathy and macular edema in acromegaly: a case report and literature review.
Diabetol Int. 2022 Jan 25;13(3):575-579. doi: 10.1007/s13340-022-00571-4. eCollection 2022 Jul.
5
Somatostatin and diabetic retinopathy: an evolving story.
Endocrine. 2018 Apr;60(1):1-3. doi: 10.1007/s12020-018-1561-0. Epub 2018 Feb 20.
6
Retinal Neural and Vascular Structure in Isolated Growth Hormone Deficiency Children and Evaluation of Growth Hormone Treatment Effect.
J Clin Res Pediatr Endocrinol. 2018 Jun 1;10(2):113-118. doi: 10.4274/jcrpe.4758. Epub 2017 Oct 30.
7
Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.
World J Diabetes. 2017 Jul 15;8(7):317-329. doi: 10.4239/wjd.v8.i7.317.

本文引用的文献

1
The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
Ann Endocrinol (Paris). 2012 Jun;73(3):190-201. doi: 10.1016/j.ando.2012.05.001. Epub 2012 Jun 9.
2
Predictors of morbidity and mortality in acromegaly: an Italian survey.
Eur J Endocrinol. 2012 Aug;167(2):189-98. doi: 10.1530/EJE-12-0084. Epub 2012 May 17.
3
Goiter, cardiovascular and metabolic disorders in patients with acromegaly.
Endocr Regul. 2011 Oct;45(4):191-7. doi: 10.4149/endo_2011_04_191.
4
Proliferative diabetic retinopathy in acromegaly.
Oman J Ophthalmol. 2010 May;3(2):96-7. doi: 10.4103/0974-620X.64237.
5
The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.
Curr Med Chem. 2006;13(27):3307-17. doi: 10.2174/092986706778773086.
7
Growth factors in proliferative diabetic retinopathy.
Exp Diabesity Res. 2003 Oct-Dec;4(4):287-301. doi: 10.1155/EDR.2003.287.
10
Severe proliferative diabetic retinopathy associated with acromegaly.
Br J Ophthalmol. 1999 May;83(5):629-30. doi: 10.1136/bjo.83.5.628c.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验